跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTILYSE CATHFLO alteplase (rch) 2 mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
ACTILYSE CATHFLO alteplase (rch) 2 mg powder for injection vial
Approved
STANDARD
ACTILYSE CATHFLO alteplase (rch) 2 mg powder for injection vial
Boehringer Ingelheim Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
de539b09f29d4158
Company
Boehringer Ingelheim Pty Ltd
Type
Standard
Approval Details
Approval Id
de539b09f29d4158
Product Name
ACTILYSE CATHFLO alteplase (rch) 2 mg powder for injection vial
Artg Id
142795
Artg Name
ACTILYSE CATHFLO alteplase (rch) 2 mg powder for injection
Sponsor
Boehringer Ingelheim Pty Ltd
Company Detail Path
/organization/boehringer-ingelheim-pty-ltd
Artg Date
2008-06-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5344110fbb4631bc146770c5b5b0a7d4.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dbd3d5c8e26fe9ae69ca52a4f2fcc2f1.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
de539b09f29d4158
Type
Standard
Back to TGA Approvals